Our Services

Expert pathology.
Second opinions.

QPathOne Consult, Global, and Academy — what we offer and how to access it.

QPathOne Consult

Specialist second opinions.

Our core service. A UK GMC-registered and US board-certified Consultant pathologist reviews your histopathology case and issues a structured second opinion — delivered directly to your portal.

All major solid tumour specialties
Breast, Upper & Lower GI, Lung, Head & Neck, Thyroid, Urology, Gynaecology, Hepatobiliary, Skin, Bone, Neuropathology, Haematopathology, Cytology
Immunohistochemistry (IHC) & special stains interpretation
ER, PR, HER2, Ki-67 (Immunohistochemistry/Immunohistochemistry (IHC) markers), PAS, ZN, Masson, Reticulin, Congo Red, Grocott and more — with clone and scoring commentary
Structured reports with confidence grading
Morphological findings, Immunohistochemistry (IHC) interpretation, primary diagnosis, diagnostic confidence grading, and clinical recommendations
MDT & Tumour board prepared
Reports formatted and timed for multidisciplinary meeting discussion — urgent reports available within 24–48 hours
Routine report
2–5 days
Full structured second opinion. Suitable for elective cases, MDT preparation, and non-urgent diagnostic queries.
Urgent report
24–48 hrs
Priority review for upcoming MDT meetings, Tumour boards, or time-sensitive treatment decisions.
Ready to submit a case?
Access the platform or contact us directly.
QPathOne Global

Partnerships & global health.

We work with hospitals, health systems, and NGOs across Nigeria, sub-Saharan Africa, Asia, and beyond — building pathology capacity where it is needed most.

🏥
Hospital partnerships

Formal partnership agreements with oncology centres and specialist hospitals — including billing agreements and dedicated turnaround commitments.

🤝
NGO & global health

We are open to partnerships with global health organisations, charities, and academic institutions working to improve cancer outcomes in low-resource settings.

📊
Research collaboration

Interested in research partnerships or data collaboration? We welcome conversations with academic pathology departments and research institutions.